QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, December 12, 2007, 27(50):13624-13634; doi:10.1523/JNEUROSCI.2858-07.2007

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Kurrasch, D. M. Articles by Ingraham, H. A. Search for Related Content PubMed PubMed Citation Articles by Kurrasch, D. M. Articles by Ingraham, H. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Substance via MeSH

 Previous Article  |  Next Article 

Development/Plasticity/Repair
The Neonatal Ventromedial Hypothalamus Transcriptome Reveals Novel Markers with Spatially Distinct Patterning

Deborah M. Kurrasch, ^* Clement C. Cheung, ^* Florence Y. Lee, Phu V. Tran, Kenji Hata, and Holly A. Ingraham

Departments of Physiology and Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94143

Correspondence should be addressed to Holly A. Ingraham, Department of Physiology and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 1550 4th Street, San Francisco, CA 94143-2611. Email: holly.ingraham{at}ucsf.edu

The ventromedial hypothalamus (VMH) is a distinct morphological nucleus involved in feeding, fear, thermoregulation, and sexual activity. It is essentially unknown how VMH circuits underlying these innate responses develop, in part because the VMH remains poorly defined at a cellular and molecular level. Specifically, there is a paucity of cell-type-specific genetic markers with which to identify neuronal subgroups and manipulate development and signaling in vivo. Using gene profiling, we now identify 200 genes highly enriched in neonatal (postnatal day 0) mouse VMH tissue. Analyses of these VMH markers by real or virtual (Allen Brain Atlas; http://www.brain-map.org) experiments revealed distinct regional patterning within the newly formed VMH. Top neonatal markers include transcriptional regulators such as Vgll2, SF-1, Sox14, Satb2, Fezf1, Dax1, Nkx2-2, and COUP-TFII, but interestingly, the highest expressed VMH transcript, the transcriptional coregulator Vgll2, is completely absent in older animals. Collective results from zebrafish knockdown experiments and from cellular studies suggest that a subset of these VMH markers will be important for hypothalamic development and will be downstream of SF-1, a critical factor for normal VMH differentiation. We show that at least one VMH marker, the AT-rich binding protein Satb2, was responsive to the loss of leptin signaling (Lep^ob/ob) at postnatal day 0 but not in the adult, suggesting that some VMH transcriptional programs might be influenced by fetal or early postnatal environments. Our study describing this comprehensive "VMH transcriptome" provides a novel molecular toolkit to probe further the genetic basis of innate neuroendocrine behavioral responses.

Key words: VMH; SF-1; CNS development; gene profiling; hypothalamus; Vgll2; zebrafish

---

Received June 22, 2007; revised Oct. 11, 2007; accepted Oct. 16, 2007.

Correspondence should be addressed to Holly A. Ingraham, Department of Physiology and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 1550 4th Street, San Francisco, CA 94143-2611. Email: holly.ingraham{at}ucsf.edu

This article has been cited by other articles:

				K. W. Kim, Y.-H. Jo, L. Zhao, N. R. Stallings, S. C. Chua Jr, and K. L. Parker Steroidogenic Factor 1 Regulates Expression of the Cannabinoid Receptor 1 in the Ventromedial Hypothalamic Nucleus Mol. Endocrinol., August 1, 2008; 22(8): 1950 - 1961. [Abstract] [Full Text] [PDF]

				L. Zhao, K. W. Kim, Y. Ikeda, K. K. Anderson, L. Beck, S. Chase, S. A. Tobet, and K. L. Parker Central Nervous System-Specific Knockout of Steroidogenic Factor 1 Results in Increased Anxiety-Like Behavior Mol. Endocrinol., June 1, 2008; 22(6): 1403 - 1415. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help